通过调节PLOD3,RBM15增加了ESCC中瘤透的CD4+T细胞

Xuyang Lin1,2, Xiao Han3, Wubi Zhou4

  • 1Department of Stomatology, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University Huai'an 223001, Jiangsu, China.

PubMed
概括

聚烯-氨酸,2-氧格酸盐5-二氧化酶3 (PLOD3) 和RBM15是食道状细胞癌 (ESCC) 的关键预后因素. RBM15调节PLOD3,增强CD4+T细胞透,改善ESCC的预后.